Linked bibliography for the SEP article "The Ethics of Clinical Research" by David Wendler
This is an automatically generated and experimental page
If everything goes well, this page should display the bibliography of the aforementioned article as it appears in the Stanford Encyclopedia of Philosophy, but with links added to PhilPapers records and Google Scholar for your convenience. Some bibliographies are not going to be represented correctly or fully up to date. In general, bibliographies of recent works are going to be much better linked than bibliographies of primary literature and older works. Entries with PhilPapers records have links on their titles. A green link indicates that the item is available online at least partially.
This experiment has been authorized by the editors of the Stanford Encyclopedia of Philosophy. The original article and bibliography can be found here.
- Angell, M., 2008. “Industry sponsored clinical research: a
broken system,” Journal of the American Medical
Association, 80: 899–904. (Scholar)
- Appelbaum, P.S., with C.W. Lidz and T. Grisso, 2004. “Therapeutic misconception in clinical research: frequency and risk factors,” IRB: Ethics and Human Research, 26: 1–8. (Scholar)
- Australian Government, National Health and Medical Research
Council, 1999. National statement on ethical conduct in research
involving humans. Ch 2.1: 92. Commonwealth of Australia,
1999. (Scholar)
- Beecher, H. K., 1966. “Ethics and clinical research,”
N Engl J Med, 274: 1354–60. (Scholar)
- Brock, D. W., 1994. “Ethical issues in exposing children to
risks in research,” Chapter 3 (pp. 81–101) of Grodin and
Glantz (eds.), Children as Research Subjects, New York:
Oxford University Press. (Scholar)
- Brody, B.A., 1998. The Ethics of Biomedical Research: An International Perspective, Oxford: Oxford University Press. (Scholar)
- Caldwell, P.H.Y., with S.B. Murphy, P.H. Butow, and J.C. Craig,
2004. “Clinical trials in children,” Lancet, 364:
803–11. (Scholar)
- Caplan, A., 1984. “Is there a duty to serve as a subject in biomedical research?” IRB: Ethics and Human Research, 6: 1–5. (Scholar)
- Committee on the Learning Health Care System in America; Institute
of Medicine; Smith M, Saunders R, Stuckhardt L, et
al. (eds.), Best Care at Lower Cost: The Path to Continuously
Learning Health Care in America, Washington, D.C.: National
Academies Press; 2013 May 10. (Scholar)
- Council for International Organizations of Medical Sciences, 2002.
International ethical guidelines for biomedical research involving
human subjects. Geneva: CIOMS. (Scholar)
- Croghan, T.W., and P.M. Pittman, 2004. “The medicine
cabinet: What’s in it, why, and can we change the
contents?” Health Affairs, 23: 23–33. (Scholar)
- D’Arcy Hart, P., 1999. “A change in scientific
approach: From alternation to randomised allocation in clinical trials
in the 1940s,” BMJ, 319: 572–3. (Scholar)
- Department of Health and Human Services, 2005. Code of Federal
Regulations: Title 45 (Public Welfare). Part 46: protection of
human subjects (45 CFR 46). US Government Printing Office. (Scholar)
- Dworkin, R., 1989, “The original position,” in
Reading Rawls, Norman Daniels (ed.), Stanford: Stanford
University Press, 16–53. (Scholar)
- Dworkin, G., 2005. “Paternalism,” in Stanford
Encyclopedia of Philosophy (Winter 2005 Edition), Edward N. Zalta
(ed.), URL =
<https://plato.stanford.edu/archives/win2005/entries/paternalism/>. (Scholar)
- Elliott, C., 2008, “Guinea-pigging,” The New
Yorker, January 7, 2008, p. 36. (Scholar)
- Emanuel, E.J., with D. Wendler and C. Grady 2000. “What
makes clinical research ethical?,” Journal of the American
Medical Association, 283: 2701–11. (Scholar)
- Faden, R.R., and T.L. Beauchamp, 1986. A History and Theory of
Informed Consent, New York: Oxford University Press, pp.
200–232. (Scholar)
- Faden, R.R., N.E. Kass, S.N. Goodman, P. Pronovost, S. Tunis, and
T.L Beauchamp. An ethics framework for a learning health care system:
a departure from traditional research ethics and clinical ethics,
Hastings Center Report 2013; Spec No: S16-27. (Scholar)
- Featherstone, K., and J.L. Donovan, 2002. “Why don’t
they just tell me straight, why allocate it? The struggle to make
sense of participating in a randomised controlled trial,”
Social Science and Medicine, 55: 709–19. (Scholar)
- Feinberg, J., 1986. Harm to Self, Oxford: Oxford University Press, pp. 3–26. (Scholar)
- Field, M.J., and R.E. Behrman, 2004. The Ethical Conduct of
Clinical Research Involving Children, Washington DC: National
Academies Press, Ch. 2. (Scholar)
- Flory, J., and E. Emanuel, 2004. “Interventions to improve
research participants’ understanding in informed consent for
research: A systematic review,” Journal of the American
Medical Association, 292: 1593–1601. (Scholar)
- Fontanarosa P.B., with A. Flanagin A. and C.D. DeAngelis, 2005.
“Reporting conflicts of interest, financial aspects of research,
and role of sponsors in funded studies,” Journal of the
American Medical Association, 294: 110–11. (Scholar)
- Freedman, B., 1987. “Equipoise and the ethics of clinical
research,” The New England Journal of Medicine, 317:
141–45. (Scholar)
- Friedman M., 1970, “The social responsibility of business is
to increase its profits,” The New York Times Magazine,
September 13, 1970. (Scholar)
- Garattini S., 1997. “Are me-too drugs justified?,”
J Nephrol, 10: 283–94. (Scholar)
- Gauthier, D., 1990. Morals by Agreement, Oxford:
Clarendon Press. (Scholar)
- Gifford, F., 2007. “Pulling the plug on clinical equipoise: A critique of Miller and Weijer,” Kennedy Institute of Ethics Journal, 17: 203–26. (Scholar)
- Goodyear, M.D., with K. Krleza-Jeric and T. Lemmens, 2007.
“The Declaration of Helsinki,” BMJ, 335:
624–5. (Scholar)
- Grady, C., 2005. “Payment of clinical research
subjects,” J Clin Invest, 115: 1681–7. (Scholar)
- Griffin, J., 1986. Well-being: Its Meaning, Measurement and Moral Importance, Oxford: Clarendon. (Scholar)
- Grodin, M.A., and G.J. Annas, 1996. “Legacies of Nuremberg:
Medical ethics and human rights,” Journal of the American
Medical Association, 276: 1682–83. (Scholar)
- Harmon, A., 2010. “Indian Tribe Wins Fight to Limit Research
of Its DNA,” New York Times, 21 April 2010. (Scholar)
- Harris, J., 2005. “Scientific research is a moral duty,” Journal of Medical Ethics, 31: 242–48. (Scholar)
- Hayenhjelm, M., and J. Wolff, 2012. “The moral problem of risk impositions: A survey of the literature,” European Journal of Philosophy, 20 (Supplement S1): E26–E51. (Scholar)
- Hellman, S., and D.S. Hellman, 1991. “Of mice but not men:
Problems of the randomized clinical trial,” The New England
Journal of Medicine, 324: 1585–89. (Scholar)
- Heyd, D., 1996. “Experimentation on trial: Why should one take part in medical research?”, Jahrbuch fur Recht und Ethik [Annual Review of Law and Ethics], 4: 189–204. (Scholar)
- Huskamp, H.A., 2006. “Prices, profits, and innovation:
Examining criticisms of new psychotropic drugs’ value,”
Health Affairs, 25: 635–46. (Scholar)
- Jonas, H., 1969. “Philosophical reflections on experimenting
with human subjects”, Daedalus, 98: 219–247. (Scholar)
- Katz, J., 1996. “The Nuremberg Code and the Nuremberg trial.
A reappraisal,” Journal of the American Medical
Association 276: 1662–6. (Scholar)
- Kopelman, L.M., 2000. “Children as research subjects: A dilemma,” Journal of Medicine and Philosophy, 25: 745–64. (Scholar)
- Kupst, M.J., with A.F. Patenaude, G.A. Walco, and C. Sterling,
2003. “Clinical trials in pediatric cancer: Parental
perspectives on informed consent,” Journal of Pediatric
Hematology and Oncology, 25: 787–90. (Scholar)
- Lazarou, J., with B.H. Pomeranz and P.N. Corey, 1998.
“Incidence of adverse drug reactions in hospitalized patients: A
meta-analysis of prospective studies,” Journal of the
American Medical Association; 279: 1200–05. (Scholar)
- Lederer, S.E., 1995. Subjected to Science: Human
Experimentation in America before the Second World War.
Baltimore: Johns Hopkins University Press. (Scholar)
- –––, 2003, “Children as guinea pigs:
Historical perspective,” Accountability in Research,
10(1): 1–16. (Scholar)
- Lederer, S.E., and M.A. Grodin, “Historical overview:
Pediatric experimentation,” in M.A. Grodin and L.H. Glantz
(eds.), Children as Research Subjects: Science, Ethics and
Law, New York: Oxford University Press, 1994. (Scholar)
- Levine, R.J., 1988. Ethics and Regulation of Clinical Research. 2nd ed. New Haven, Conn: Yale University Press. (Scholar)
- Macklin, R., 1981. “Due and undue inducements: On paying money to research subjects,” IRB: A Review of Human Subjects Research, 3: 1–6. (Scholar)
- Mervis, J., 2004. “U.S. Science budget: Caught in a squeeze
between tax cuts and military spending,” Science, 30:
587. (Scholar)
- –––, 2008. “U.S. Budget: Promising year
ends badly after fiscal showdown squeezes science,”
Science, 319: 18–9. (Scholar)
- Mill, John Stuart, 1869, On Liberty. Page reference to
On Liberty and Other Writings, Stefan Collini (ed.),
Cambridge, Cambridge University Press, 2005, 12th edition. (Scholar)
- Miller, F.G., and H. Brody, 2007. “Clinical equipoise and the incoherence of research ethics,” Journal of Medicine and Philosophy, 32: 151–65. (Scholar)
- Miller, F.G., and A. Wertheimer, 2007. “Facing up to paternalism in research ethics,” Hastings Center Report, 37: 24–34. (Scholar)
- Miller, P.B., and C. Weijer, 2006. “Trust based obligations of the state and physician-researchers to patient-subjects,” Journal of Medical Ethics, 32: 542–47. (Scholar)
- National Bioethics Advisory Commission (NBAC), 2001. Ethical
and Policy Issues in Research Involving Human Participants.
Washington, DC: NBAC. (Scholar)
- Nicholson, R.H., 1986. Medical Research with Children: Ethics, Law, Practice. Oxford: Oxford University Press. Pages 87–100. (Scholar)
- Nuremberg Code, 1947, in Trials of war criminals before the
Nuremberg Military Tribunals under Control Council Law No. 10,
Vol. 2, Washington, D.C.: U.S. Government Printing Office, 1949, pp.
181–182. Reprinted in Journal of the American Medical
Association, 276: 1961. (Scholar)
- Psaty, B.M., and R.A. Kronmal, 2008. “Reporting mortality
findings in trials of rofecoxib for Alzheimer disease or cognitive
impairment: A case study based on documents from rofecoxib
litigation,” Journal of the American Medical
Association, 299: 1813–7. (Scholar)
- Ramsey, P., 1978. “Ethical dimensions of experimental
research on children”, in Research on Children: Medical
Imperatives, Ethical Quandaries, and Legal Constraints, J. van
Eys (ed.), Baltimore: University Park Press, p. 61. (Scholar)
- Rawls, J., 1999. A Theory of Justice. Cambridge, Mass: Belknap Press of Harvard University Press. (Scholar)
- Resnik, D.B., 2005. “Eliminating the daily life risks standard from the definition of minimal risk,” Journal of Medical Ethics, 31: 35–8. (Scholar)
- Rid, A., and D. Wendler, 2011. “A framework for risk-benefit
evaluations in biomedical research,” Kennedy Institute of
Ethics Journal, 21(2): 141–179.
- Roberts, R., with W. Rodriquez, D. Murphy, and T. Crescenzi, 2003.
“Pediatric drug labeling: Improving the safety and efficacy of
pediatric therapies,” Journal of the American Medical
Association, 290: 905–11. (Scholar)
- Ross, L.F., and R.M. Nelson, 2006. “Pediatric research and
the federal minimal risk standard,” Journal of the American
Medical Association, 295: 759. (Scholar)
- Rothman, D.J., 2000. “The shame of medical research”,
The New York Review of Books, 47 (19): 60–64. (Scholar)
- Sachs, Ben, 2010. “The exceptional ethics of the investigator-subject relationship,” Journal of Medicine and Philosophy, 35: 64–80. (Scholar)
- Shuster, E., 1997. “Fifty years later: The significance of
the Nuremberg Code,” The New England Journal of
Medicine, 337: 1436–40. (Scholar)
- Slovic, P., 1987. “Perception of risk,”
Science, 236: 280–85. (Scholar)
- Snowdon, C., with J. Garcia, and D. Elbourne, 1997. “Making
sense of randomization: Responses of parents of critically ill babies
to random allocation of treatment in a clinical trial,”
Social Science and Medicine, 45: 1337–55. (Scholar)
- Spilker, B., 1991. Guide to clinical trials,
Philadelphia: Lippincott, Williams and Wilkins. (Scholar)
- Stark, C., 2000. “Hypothetical consent and justification,” Journal of Philosophy, 97: 313–34. (Scholar)
- Stewart, Paul M., with Anna Stears, Jeremy W. Tomlinson, and
Morris J. Brown, 2008. “Regulation—the real threat to
clinical research,” British Medical Journal, 337:
1085–1087. (Scholar)
- Sullivan, Richard, 2008. “The good, the bad and the ugly:
Effect of regulation on cancer research,” Lancet
Oncology, 9: 2–3. (Scholar)
- Sutton, G., 2003. “Putrid gums and ‘dead men’s
cloaths’: James Lind aboard the Salisbury,” Journal of
the Royal Society of Medicine, 96: 605–8. (Scholar)
- Tversky, A., and D. Kahneman, 1974. “Judgments under uncertainty: Heuristics and biases,” Science, 185: 1124–31. (Scholar)
- –––, 1981, “The framing of decisions and
the rationality of choice,” Science, 211:
453–8. (Scholar)
- Vollmann J., and R. Winau, 1996. “Informed consent in human
experimentation before the Nuremberg code,” British Medical
Journal, 313: 1445–7. (Scholar)
- Weinstein, N., 1989. “Optimistic biases about personal
risks,” Science, 246: 1232–3. (Scholar)
- Wenar, L., 2008. “John Rawls”, The Stanford Encyclopedia of Philosophy (Summer 2008 Edition), Edward N. Zalta (ed.), URL = <https://plato.stanford.edu/archives/sum2008/entries/rawls/>. (Scholar)
- Wendler, D., 2010, The Ethics of Pediatric Research, Oxford: Oxford University Press. (Scholar)
- Wertheimer, A., 2008. “Exploitation”, The Stanford
Encyclopedia of Philosophy (Fall 2008 Edition), Edward N. Zalta
(ed.), URL =
<https://plato.stanford.edu/archives/fall2008/entries/exploitation/>. (Scholar)
- –––, 2010, Rethinking the Ethics of Clinical Research: Widening the Lens, Oxford: Oxford University Press. (Scholar)
- Wilson, James, and David Hunter, 2010. “Research exceptionalism,” American Journal of Bioethics, 10: 45–54. (Scholar)
- World Medical Organization, 1996. Declaration of
Helsinki, British Medical Journal, 313 (7070):
1448–1449. (Scholar)